Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Inception IBD
AddedMar 20, 2024
UpdatedJun 18, 2026
Inception IBD

Inception IBD

Series A

Translating academic IBD discoveries.

HQ
San Diego, CA, US
Founded
2014
Overview
Compare
Fundraising
Employees

Inception IBD is dedicated to translating academic discoveries in the field of inflammatory bowel disease (IBD) into practical applications. The company aims to bridge the gap between research and real-world treatment, focusing on innovative solutions to improve patient outcomes. Their market focus includes healthcare providers, researchers, and patients affected by IBD.

Inception IBD has made significant strides in bringing cutting-edge research to the forefront of IBD treatment. By collaborating with leading academic institutions and leveraging advanced technologies, the company has contributed to the development of new therapies and diagnostic tools. Their efforts have had a notable impact on the IBD community, enhancing the quality of care and expanding treatment options.

Inception IBD - Similar Companies

Precision IBD logo

Precision IBD

Inception Sciences logo

Inception Sciences

Inflammatory Response Research logo

Inflammatory Response Research

irrinc.net

Intellimedix logo

Intellimedix

Celdara Medical logo

Celdara Medical

Ibd Associates logo

Ibd Associates

ibd-associates.com

Aibios logo

Aibios

aibios.com

Empire Biotechnologies logo

Empire Biotechnologies

White Sands Pharma logo

White Sands Pharma

Imidomics logo

Imidomics

imidomics.com

Ibex Biosciences logo

Ibex Biosciences

ibex.bio

Incept BioSystems logo

Incept BioSystems

Intrance Medical Systems logo

Intrance Medical Systems

Enterin logo

Enterin

enterininc.com

Incube Labs logo

Incube Labs

incubelabs.com

Inception IBD - Quick Facts

Who are Inception IBD's competitors?

Companies similar to Inception IBD include Precision IBD, Inception Sciences, Inflammatory Response Research and Intellimedix.

When was Inception IBD founded?

Inception IBD was founded in 2014.

Where is Inception IBD's headquarters located?

Inception IBD's headquarters is located in San Diego, CA, US.

When was Inception IBD's last funding round?

Inception IBD's most recent funding round was for $14.1M (USD) in December 2015.

How much has Inception IBD raised to-date?

As of Dec 10, 2015, Inception IBD has raised a total of $14.1M (USD).

How many employees does Inception IBD have?

Inception IBD has 30 employees as of Feb 5, 2024.

Inception IBD - Classification

Ownership
  • Private
Technology
  • Biotech
  • HealthTech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Analytics
Tags
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 9 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified